Caden Biosciences, which relocated to Madison amid great fanfare and after securing nearly $6 million in venture capital from Illinois and Wisconsin investors, has closed its doors. Caden had been developing a tool to help researchers screen for additional drug targets, but company officials and...
Demand for high-tech business space continues to grow in Madison, as University Research Park has announced plans for yet another “accelerator” facility for start-up businesses on its existing campus, according to a published report. ...
Using three cell lines derived from a new technique developed in the Jamie Thomson lab at the University of Wisconsin-Madison, the WiCell Research Institute will start its own stem cell bank. The bank will distribute induced pluripotent cell lines, which are genetically reprogrammed from human...
Madison, Wis. — NanoMedex, a University of Florida spin-off pharmaceutical company, is moving its headquarters and lab to Wisconsin and has received funding from Kegonsa Capital Partners in Fitchburg, according to a report in the Milwaukee Journal-Sentinel....
Madison, Wis. — The Genetics Policy Institute (GPI) announced today that it would present its Stem Cell Action awards September 22 at the World Stem Cell Summit here, and that among the honorees is Governor Jim Doyle....
Remember Jurassic Park—the Steven Spielberg sci fi flick in which a greedy businessman and his mad-scientist minions reached inside prehistoric amber to extract, and ultimately clone, dino DNA that had been sucked up by a sap-trapped bug? Seem far fetched?...
Madison, Wis. — Madison was one of nine locations to be overlooked for a $451 million federal laboratory despite scoring higher in an evaluation than the government's selection, according to a report from the Associated Press....
The pharma and biotech industries have various ways of measuring success, but nothing is more visible than demonstrating testimonials with patients happily recounting how a drug changed their chances for life or quality of life. Unfortunately, while Wall St. might applaud such efforts, what the...
Madison, Wis. — Covance, a contract research organization (CRO) for pharmaceuticals with a presence in Madison, has signed a $1.6 billion deal to provide Eli Lily with drug development services, after buying Lily's Greenfield, Indiana, campus for $50 million....
Madison, Wis. — A team of researchers here led by James Thomson will delve further into the workings of stem cells with an $8.9 million, five-year grant from the National Institute of General Medical Sciences (NIGMS), announced today....